Spleen-Kidney Supplementing Formula Alleviates Renal Fibrosis in Diabetic Rats via TGF-β1-miR-21-PTEN Signaling Pathway

Figure 3

SKSF improved the morphology and structure of renal tissue. (a) Normal group, (b) model group, (c) metformin group, (d) Spleen-Kidney Supplementing Formula group at a high dose, (e) Spleen-Kidney Supplementing Formula group at a medium dose, (f) Spleen-Kidney Supplementing Formula group at a low dose.

(a)

(b)

(c)

(d)

(e)

(f)